176 related articles for article (PubMed ID: 32133801)
1. Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods
Wang JL; Wang Y; Ren GP
J Zhejiang Univ Sci B; 2020 Mar.; 21(3):246-255. PubMed ID: 32133801
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
3. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
5. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
Wang Y; Wang J; Tang Q; Ren G
PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
[TBL] [Abstract][Full Text] [Related]
6. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
Cheng Y; Li L; Qin Z; Li X; Qi F
J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z
Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes associated with castration‑resistant prostate cancer by gene expression profile analysis.
Huang CG; Li FX; Pan S; Xu CB; Dai JQ; Zhao XH
Mol Med Rep; 2017 Nov; 16(5):6803-6813. PubMed ID: 28901445
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling analysis of castration-resistant prostate cancer.
Wang X; Wen J; Li R; Qiu G; Zhou L; Wen X
Med Sci Monit; 2015 Jan; 21():205-12. PubMed ID: 25592164
[TBL] [Abstract][Full Text] [Related]
11. Identification of Core Genes and Potential Drugs for Castration-Resistant Prostate Cancer Based on Bioinformatics Analysis.
Liang X; Hu K; Li D; Wang Y; Liu M; Wang X; Zhu W; Wang X; Yang Z; Lu J
DNA Cell Biol; 2020 May; 39(5):836-847. PubMed ID: 32101033
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract][Full Text] [Related]
13. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
Guo T; Hou D; Yu D
Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
18. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
19. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
20. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]